BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 3063441)

  • 1. The diagnosis and treatment of posttransplant lymphoproliferative disorders.
    Nalesnik MA; Makowka L; Starzl TE
    Curr Probl Surg; 1988 Jun; 25(6):367-472. PubMed ID: 3063441
    [No Abstract]   [Full Text] [Related]  

  • 2. Posttransplant lymphoproliferative disorder after liver and kidney transplant.
    Akar Özkan E; Özdemir BH; Deniz EE; Tunca MZ; Haberal M
    Exp Clin Transplant; 2014 Mar; 12 Suppl 1():142-8. PubMed ID: 24635813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Post-transplant lymphoproliferative disorders].
    Aguilar Escrivá A; Gómez Codina J; Munárriz Gandía B
    Med Clin (Barc); 1998 Jun; 111(1):32-6. PubMed ID: 9666434
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiac allograft involvement by post-transplantation lymphoproliferative disorder.
    Nelson KH; Chatzizisis YS; Steigner ML; Mitchell RN; Blankstein R; Givertz MM
    J Am Coll Cardiol; 2013 Sep; 62(10):937. PubMed ID: 23850919
    [No Abstract]   [Full Text] [Related]  

  • 5. Heart allograft involvement by posttransplant lymphoproliferative disorders: report from the PTLD. Int survey.
    Khedmat H; Taheri S
    Exp Clin Transplant; 2011 Aug; 9(4):258-64. PubMed ID: 21819371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Post-transplantation lymphoproliferative disorder in childhood].
    Stréhn A; Szőnyi L; Kriván G; Kovács L; Reusz G; Szabó A; Rényi I; Kovács G; Dezsőfi A
    Orv Hetil; 2014 Feb; 155(8):313-8. PubMed ID: 24534879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Otolaryngologic management of posttransplant lymphoproliferative disease in children.
    Sculerati N; Arriaga M
    Ann Otol Rhinol Laryngol; 1990 Jun; 99(6 Pt 1):445-50. PubMed ID: 2350129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posttransplant lymphoproliferative disorders in renal allograft recipients: report of 53 cases of a French multicenter study. PTLD French Working Group.
    Caillard S; Lachat V; Moulin B
    Transpl Int; 2000; 13 Suppl 1():S388-93. PubMed ID: 11112039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy.
    Starzl TE; Nalesnik MA; Porter KA; Ho M; Iwatsuki S; Griffith BP; Rosenthal JT; Hakala TR; Shaw BW; Hardesty RL
    Lancet; 1984 Mar; 1(8377):583-7. PubMed ID: 6142304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posttransplant lymphoproliferative disorder: intrathoracic manifestations.
    Dodd GD; Ledesma-Medina J; Baron RL; Fuhrman CR
    Radiology; 1992 Jul; 184(1):65-9. PubMed ID: 1609104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous lymphokine-activated killer cell therapy of lymphoproliferative disorders arising in organ transplant recipients.
    Nalesnik MA; Rao AS; Zeevi A; Fung JJ; Pham S; Furukawa H; Gritsch A; Klein G; Starzl TE
    Transplant Proc; 1997 May; 29(3):1905-6. PubMed ID: 9142315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical characteristics of patients with lymphoproliferative disorders after allogeneic hematopoietic stem cell transplant].
    Gu B; Chen GH; Wang Y
    Zhonghua Xue Ye Xue Za Zhi; 2012 Dec; 33(12):1046-9. PubMed ID: 23363801
    [No Abstract]   [Full Text] [Related]  

  • 13. Native kidney posttransplant lymphoproliferative disorder in a renal transplant recipient.
    Chandra A; Kaul A; Aggarwal V; Srivastava D
    Saudi J Kidney Dis Transpl; 2017; 28(4):942-944. PubMed ID: 28748904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EBV-negative lymphoproliferative disease with hyper-IgA, in a child with combined liver and small bowel transplantation.
    Robert CD; Lacaille F; Canioni D; Quartier-dit-Maire P; Talbotec C; Goulet O
    Pediatr Transplant; 2004 Jun; 8(3):305-7. PubMed ID: 15176970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence, management, and outcome of posttransplant lymphoproliferative disease in pediatric liver transplant recipients.
    Molmenti EP; Nagata D; Roden J; Squires R; Molmenti H; Casey D; Fasola C; Lopez MJ; Winick N; McPhail W; D'Amico L; Goldstein R; Levy M; Fasola C; Andersen J; Klintmalm G
    Transplant Proc; 2001; 33(1-2):1727. PubMed ID: 11267487
    [No Abstract]   [Full Text] [Related]  

  • 16. [Posttransplant lymphoproliferative disorder].
    Oike F; Egawa H; Haga H; Kudo T
    Nihon Rinsho; 2006 Mar; 64 Suppl 3():639-46. PubMed ID: 16615551
    [No Abstract]   [Full Text] [Related]  

  • 17. Tonsillectomy in post-transplant lymphoproliferative disease in children.
    Sturm-O'Brien AK; Hicks MJ; Giannoni CM; Sulek M; Friedman EM
    Laryngoscope; 2010 Mar; 120(3):608-11. PubMed ID: 20131364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posttransplant lymphoproliferative disorders in cardiac transplant patients.
    Fatio R; Sütsch G; Mayer K; Follath F; Corti R; Gallino A; Kiowski W
    Transplant Proc; 1998 Jun; 30(4):1118-20. PubMed ID: 9636453
    [No Abstract]   [Full Text] [Related]  

  • 19. Posttransplant lymphoproliferative disorders in heart-lung transplant recipients: primary presentation in the allograft.
    Yousem SA; Randhawa P; Locker J; Paradis IL; Dauber JA; Griffith BP; Nalesnik MA
    Hum Pathol; 1989 Apr; 20(4):361-9. PubMed ID: 2539321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular involvement in patients with posttransplant lymphoproliferative disorder.
    Cho AS; Holland GN; Glasgow BJ; Isenberg SJ; George BL; McDiarmid SV
    Arch Ophthalmol; 2001 Feb; 119(2):183-9. PubMed ID: 11176978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.